10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2018 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 20, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Revenues | |||
| Premiums | $ 85,421 | 83,648 | 78,860 |
| Administrative fees and other revenue | 5,920 | 5,413 | 5,334 |
| Total operating revenue | 91,341 | 89,061 | 84,194 |
| Net investment income | 970 | 867 | 779 |
| Net realized (losses) gains on financial instruments | (180) | 145 | 5 |
| Other than temporary impairment losses on investments: | |||
| Total other-than-temporary impairment losses on investments | (29) | (35) | (147) |
| Portion of other-than-temporary impairment losses recognized in other comprehensive income | 3 | 2 | 32 |
| Other-than-temporary impairment losses recognized in income | (26) | (33) | (115) |
| Total revenues | 92,105 | 90,040 | 84,863 |
| Expenses | |||
| Benefit expense | 71,895 | 72,236 | 66,834 |
| Selling, general and administrative expense | 14,020 | 12,650 | 12,559 |
| Interest expense | 753 | 739 | 723 |
| Amortization of other intangible assets | 358 | 169 | 192 |
| Loss on extinguishment of debt | 11 | 282 | 0 |
| Total expenses | 87,037 | 86,076 | 80,308 |
| Income before income tax expense | 5,068 | 3,964 | 4,555 |
| Income tax expense | 1,318 | 121 | 2,085 |
| Net income | 3,750 | 3,843 | 2,470 |
| Net income per share | |||
| Basic net income per share | 14.53 | 14.70 | 9.39 |
| Diluted net income per share: | |||
| Diluted net income per share | 14.19 | 14.35 | 9.21 |
| Dividends per share | 3.00 | 2.70 | 2.60 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2018 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 20, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Net income | $ 3,750 | 3,843 | 2,470 |
| Other comprehensive income (loss), net of tax: | |||
| Change in net unrealized gains/losses on investments | (418) | 173 | 118 |
| Change in non-credit component of other-than-ternporary impairment losses on investments | (2) | 4 | 5 |
| Change in net unrealized gains/losses on cash flow hedges | 37 | (65) | (87) |
| Change in net periodic pension and postretirement costs | (90) | 51 | (13) |
| Foreign currency translation adjustments | (1) | 3 | 2 |
| Other comprehensive (loss) income | (474) | 166 | 25 |
| Total comprehensive income | 3,276 | 4,009 | 2,495 |
| Consolidated Entities | |||
| Anthem, Inc. | |||
| Net income | 3,750 | 3,843 | 2,470 |
| Change in net unrealized gains/losses on investments | (418) | 173 | 118 |
| Change in non-credit component of other-than-ternporary impairment losses on investments | (2) | 4 | 5 |
| Change in net unrealized gains/losses on cash flow hedges | 37 | (65) | (87) |
| Change in net periodic pension and postretirement costs | (90) | 51 | (13) |
| Foreign currency translation adjustments | (1) | 3 | 2 |
| Other comprehensive (loss) income | (474) | 166 | 25 |
| Total comprehensive income | 3,276 | 4,009 | 2,495 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2018 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 20, 2019) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Operating activities | |||
| Net income | $ 3,750 | 3,843 | 2,470 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized losses (gains) on financial instruments | 180 | (145) | (5) |
| Other-than-temporary impairment losses recognized in income | 26 | 33 | 115 |
| Loss on extinguishment of debt | 11 | 282 | 0 |
| Loss on disposal of assets | 8 | 13 | 5 |
| Deferred income taxes | 91 | (1,272) | 127 |
| Amortization, net of accretion | 1,008 | 780 | 808 |
| Depreciation expense | 124 | 111 | 104 |
| Impairment of property and equipment | 5 | 2 | 45 |
| Share-based compensation | 226 | 170 | 165 |
| Excess tax benefits from share-based compensation | 0 | 0 | (54) |
| Changes in operating assets and liabilities: | |||
| Receivables, net | (695) | (22) | (1,381) |
| Other invested assets | (1) | (36) | (19) |
| Other assets | (26) | (629) | (128) |
| Policy liabilities | (1,059) | 732 | 322 |
| Unearned income | (36) | (120) | (174) |
| Accounts payable and accrued expenses | 122 | 922 | 182 |
| Other liabilities | (25) | (120) | 606 |
| Income taxes | 323 | (194) | 179 |
| Other, net | (205) | (165) | (97) |
| Net cash provided by operating activities | 3,827 | 4,185 | 3,270 |
| Investing activities | |||
| Purchases of fixed maturity securities | (8,244) | (9,795) | (10,158) |
| Proceeds from fixed maturity securities: | |||
| Sales | 6,442 | 7,932 | 8,636 |
| Maturities, calls and redemptions | 1,938 | 1,848 | 1,419 |
| Purchases of equity securities | (896) | (5,416) | (1,476) |
| Proceeds from sales of equity securities | 2,809 | 3,463 | 1,593 |
| Purchases of other invested assets | (531) | (1,164) | (433) |
| Proceeds from sales of other invested assets | 411 | 219 | 305 |
| Changes in collateral and settlement of non-hedging derivatives | 0 | 65 | (35) |
| Changes in securities lending collateral | (149) | 625 | 222 |
| Purchases of subsidiaries, net of cash acquired | (1,760) | (2,080) | 0 |
| Purchases of property and equipment | (1,208) | (800) | (584) |
| Proceeds from sales of property and equipment | 0 | 9 | 0 |
| Other, net | (71) | 12 | (3) |
| Net cash used in investing activities | (1,259) | (5,082) | (514) |
| Financing activities | |||
| Net (repayments of) proceeds from commercial paper borrowings | (107) | 175 | (53) |
| Proceeds from long-term borrowings | 835 | 5,458 | 0 |
| Repayments of long-term borrowings | (1,684) | (2,815) | 0 |
| Proceeds from short-term borrowings | 9,120 | 5,835 | 2,400 |
| Repayments of short-term borrowings | (9,250) | (5,000) | (2,500) |
| Changes in securities lending payable | 150 | (625) | (222) |
| Changes in bank overdrafts | (210) | 71 | 513 |
| Proceeds from sale of put options | 1 | 1 | 0 |
| Proceeds from issuance of common stock under Equity Units stock purchase agreements | 1,250 | 0 | 0 |
| Repurchase and retirement of common stock | (1,685) | (1,998) | 0 |
| Change in collateral and settlements of debt-related derivatives | 23 | (149) | (360) |
| Cash dividends | (776) | (705) | (684) |
| Proceeds from issuance of common stock under employee stock plans | 173 | 225 | 120 |
| Taxes paid through withholding of common stock under employee stock plans | (81) | (46) | (67) |
| Excess tax benefits from share-based compensation | 0 | 0 | 54 |
| Net cash (used in) provided by financing activities | (2,241) | 427 | (799) |
| Effect of foreign exchange rates on cash and cash equivalents | (2) | 4 | 5 |
| Change in cash and cash equivalents | 325 | (466) | 1,962 |
| Cash and cash equivalents at beginning of year | 3,609 | 4,075 | |
| Cash and cash equivalents at end of year | 3,934 | 3,609 | 4,075 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELEVANCE HEALTH, INC. | ||
Ticker: ELV Fiscal Year: 2018 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 20, 2019) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2018 | Dec 31, 2017 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 3,934 | 3,609 |
| Investments available-for-sale, at fair value: | ||
| Fixed maturity securities, current (amortized cost of $16,894 and $17,055) | 16,692 | 17,377 |
| Equity Securities, Current | 1,493 | 3,599 |
| Other invested assets, current | 21 | 17 |
| Accrued investment income | 162 | 163 |
| Premiums Receivable, Net | 4,465 | 3,605 |
| Self-Funded Receivables, Net | 2,278 | 2,580 |
| Other receivables | 2,558 | 2,267 |
| Income taxes receivable | 10 | 342 |
| Securities lending collateral | 604 | 455 |
| Other current assets | 2,104 | 2,249 |
| Total current assets | 34,321 | 36,263 |
| Long-term investments available-for-sale, at fair value: | ||
| Fixed maturity securities (amortized cost of $486 and $555) | 487 | 561 |
| Equity securities | 33 | 33 |
| Other invested assets, long-term | 3,726 | 3,344 |
| Property and equipment, net | 2,735 | 2,175 |
| Goodwill | 20,504 | 19,231 |
| Other intangible assets | 9,007 | 8,368 |
| Other noncurrent assets | 758 | 565 |
| Total assets | 71,571 | 70,540 |
| Liabilities and shareholders' equity | ||
| Medical claims payable | 7,454 | 7,992 |
| Reserves for future policy benefits | 75 | 70 |
| Other policyholder liabilities | 2,590 | 2,950 |
| Total policy liabilities | 10,119 | 11,012 |
| Unearned income | 902 | 860 |
| Accounts payable and accrued expenses | 4,959 | 5,024 |
| Security trades pending payable | 197 | 113 |
| Securities lending payable | 604 | 454 |
| Short-term borrowings | 1,145 | 1,275 |
| Current portion of long-term debt | 849 | 1,275 |
| Other current liabilities | 3,190 | 3,343 |
| Total current liabilities | 21,965 | 23,356 |
| Long-term debt, less current portion | 17,217 | 17,382 |
| Reserves for future policy benefits, noncurrent | 706 | 647 |
| Deferred tax liabilities, net | 1,960 | 1,727 |
| Other noncurrent liabilities | 1,182 | 925 |
| Total liabilities | 43,030 | 44,037 |
| Commitments and contingencies-Note 13 | ||
| Shareholders' equity | ||
| Preferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none | 0 | 0 |
| Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 257,395,577 and 256,084,913 | 3 | 3 |
| Additional paid-in capital | 9,536 | 8,547 |
| Retained earnings | 19,988 | 18,054 |
| Accumulated other comprehensive loss | (986) | (101) |
| Total shareholders' equity | 28,541 | 26,503 |
| Total liabilities and shareholders' equity | 71,571 | 70,540 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |